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Abstract.  Platelet shape change induced by ADP is 
relatively independent of external pH over the range 
6-7.  If the chloride ion in the buffer is replaced by 
weak acids, however, shape change is rapidly and 
reversibly inhibited as a function of lowered pH (92% 
at pH 6.0).  This inhibition is correlated with lowered 
internal pH caused by the weak acids, as measured by 
the 5,5-dimethyloxazolidine 2,4-dione technique. Shape 
change was 50%  inhibited at internal pH 6.4 when 
50 mM NaCI was replaced by propionate (PR). When 
platelets were stimulated with ADP 10-20 s after addi- 
tion of PR to a final pH of 6 (PR6), both myosin light 
chain (MLC) phosphorylation and myosin and actin 
association with the cytoskeleton were reduced in 
correlation with the inhibition of shape change. But 
when ADP was added 30 s after PR6, the MLC phos- 
phorylation was essentially the same in PR or in chlo- 
ride, although shape change and myosin and actin as- 
sociation with the cytoskeleton remained inhibited. 
This was shown to be due mainly to endogenous phos- 
phorylation of MLC. On return to neutral pH, plate- 
lets in PR immediately changed shape and myosin and 
actin became associated with the cytoskeleton. Two- 
dimensional tryptic peptides of MLC showed two ma- 
jor spots after PR6 treatment, indicating that both the 
MLC kinase site and the protein kinase C sites were 
phosphorylated. 
The results show that increased internal pH is not 
required for shape change, although it may affect the 
rate. In PR6,  as after phorbol esters, MLC phosphory- 
lation can be uncoupled from shape change. The as- 
sociation of myosin and actin with the cytoskeleton is 
closely correlated with shape change, suggesting that 
shape change requires the active interaction of these 
contractile proteins. 
M 
ANY  cells  form ruffled  membranes and change 
shape  during locomotion or  morphogenesis  or 
when stimulated with agonists. Often these changes 
are asynchronous or slow, making them difficult to study. 
Mammalian blood platelets circulate as resting suspensions 
of anucleate disks, which rapidly and synchronously change 
shape when stimulated with agonists. The change includes 
formation of filopodia and lamellipodia,  which are similar 
to fine ruffled membranes (Born, 1970; Daniel et al., 1984; 
Zucker and Nachmias,  1985). The response can be conve- 
niently followed by measuring absorbance of stirred samples 
in correlation with microscopy. These characteristics  make 
platelets favorable objects for study of the mechanisms un- 
derlying shape change. 
Recently it has been shown that when platelets are treated 
with the agonists ADP or thrombin, phosphorylation of  myo- 
sin regulatory light chain occurs rapidly (Daniel et al., 1981; 
Fox and Phillips, 1982), and shape change occurs in correla- 
tion with the phosphorylation (Daniel et al.,  1984). When 
platelets are chilled, shape change occurs much more slowly, 
but again it is in correlation with the phosphorylation  of the 
regulatory light chain (Nachmias et al., 1985). Shape change 
and phosphorylation both return to control levels when chilled 
platelets are rewarmed. 
These correlations strongly suggest that myosin light chain 
phosphorylation is necessary for platelet shape change, and, 
since such phosphorylation  activates myosin in its interac- 
tion with actin (Adelstein and Conti,  1975), imply that shape 
change is, at least in part, caused by myosin-actin interac- 
tion. Since myosin light chain phosphorylation  requires cal- 
cium and calmodulin in vitro (Dabrowska and Hartshorne, 
1978; Hathaway and Adelstein,  1979), these results  agree 
with other evidence that there is a rise in free calcium when 
platelets  are activated.  However, it is not clear whether a 
rise in free calcium leading to the activation of myosin is 
sufficient to induce platelet  shape  change.  Other internal 
changes occur after activation (see Zucker and Nachmias, 
1985 for review). Of special interest is the rise of  0.3 pH units 
after activation  with thrombin.  Proton release,  which in- 
creases when platelets are stimulated by thrombin, is inhib- 
ited by amiloride, which inhibits sodium-proton exchange 
(Siffert et al.,  1984). Amitoride or the removal of external 
sodium strongly decreases the aggregation induced by ADP, 
epinephrine, and low doses of thrombin, or by the ionophore 
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1978; Siffert et al., 1984). It is not clear whether the change 
in internal pH (pHi) ~  is essential for shape change. Previous 
work with platelet  cytoskeletons  (Gonnella  and Nachmias, 
1981) showed  that  transformations  of short  filaments  and 
amorphous material into bundles of actin filaments could be 
induced  by incubation  in media containing  0.1-1 mM free 
calcium only if the pH were also increased  from 6.8 to 7.6. 
These results  suggested  that  cytoplasmic  pH in  the intact 
platelet  may modify the shape change  response,  and  that 
shape  change  might  be inhibited  if the pHi of the platelet 
were decreased. 
In this paper we compared the effects of lowering external 
pH or pHi on the rate of shape change. We used weak acids 
to alter pHi. Our results show that the rate of platelet shape 
change is reversibly sensitive to pHi, but 50% inhibition re- 
quires a  pHi of 6.4.  Unexpectedly,  our results  also show 
that myosin phosphorylation can be uncoupled from platelet 
shape change. 
Materials and Methods 
Platelet Preparation and Measurement 
of Shape Change 
Blood was drawn by free flow through a D-gauge butterfly from healthy hu- 
man volunteers under informed consent into 1/10 vol of 80 mM trisodium 
citrate and 70 mM citric acid. The citrated blood was centrifuged (280 g 
for 10 min) to obtain platelet-rich plasma (PRP), pH 6.6-6.8.  Shape change 
measurements were performed after Born's method (1970) in 1.5 ml samples 
in a siliconized cuvette at 37~  (light path,  1 cm) in a spectrophotometer 
(Gilford Instrument Laboratories, Inc., Oberlin, OH). The PRP was con- 
standy stirred with a specially designed magnetic stirrer. For tests at differ- 
ent pHs, platelets were diluted with solutions of propionate (PR) or chloride 
(CL) at appropriate pHs immediately before starting the measurements. Op- 
tical  density of stirred suspensions (108 platelets per ml)  was recorded 
at 609 nm using maximum sensitivity (50 mV =  0.122 A) with the chart 
speed at 5 or 15 s per inch. ADP,  10 gM final concentration, was added 
through a light tight port above the cuvette in a volume l/D0 of the final. 
Rates of shape change were estimated from the slope of the initial, linear 
portion of  the increase in absorbance. Extent of shape change was estimated 
from the final height of the absorbance record and from the diminution of 
the oscillatory signal.  Samples were examined by phase microscopy and 
scanning EM for morphological changes after agonist addition. 
pH Measurement 
The pH of the PRP diluted with different buffers was measured at the start 
and end of each experiment. Without buffer,  loss of CO2 caused an in- 
creased pH of several tenths of a unit. Imidazole and Pipes at 50 mM were 
not very effective in stabilizing external pH and higher concentrations of im- 
idazole increased platelet pHi. Sodium phosphate at 50 mM gave excellent 
stabilization. For measurements of volume and phi, PRP was diluted 1:1 
with the diluent. We found that ptatelet volumes increased after dilution in 
weak acids. Such increases are not surprising, considering the widespread 
occurrence of sodium-proton antiporters, which are activated by decreased 
phi, which leads to sodium uptake followed by water uptake (Dr. Sergio 
Grinstein, University of Toronto, personal communication). Therefore, we 
added amiloride, which inhibits sodium-proton exchange, at final concen- 
trations of 0.5-1 mM. Tritiated water was added to diluted PRP to a concen- 
tration of 6.5 ttCi/ml. This mixture was then divided into two aliquots and 
[r4C]sucrose was added to one for determination of total pellet volume and 
external volume. To the other [~4C]dimethyloxazolidinedione  (DMO) was 
added for determination of total pellet volume and pH. Both labeled com- 
1. Abbreviations used in this paper: CL, chloride; DMO, 5,5-dimethytoxa- 
zolidine 2,4-dione; pHi,  internal pH;  PR, propionate; PR6, PR at pH6; 
PRP, platelet-rieh plasma. 
pounds were also added at 6.5 ~tCi/ml. The PRP was incubated at room tem- 
perature for 1t3 rain to allow full equilibration. It was then divided into 200- 
p_L aliquots, which were layered onto silicone oil and spun for 2 min in a 
microfuge (model B; Beckman Instruments, Inc., Berkeley,  CA). Samples 
of 100 laL were mixed with 2.5 ml of Aquasol-2 (New England Nuclear, 
Boston, MA). Remaining supernatant and oil were aspirated and the pellets 
dissolved in half-saturated ammonium chloride then in Aquasol. Double- 
label counting was carried out in a scintillation spectrometer (8L-4000; In- 
tertechnique, Plaisir, France) with appropriate windows to 0.7% maximum 
error. Platelet volumes were estimated from samples containing labeled wa- 
ter and sucrose by subtraction of the included supernatant volume from the 
total pellet volume; platelet pH, was estimated from samples containing la- 
beled water and DMO.  Preliminary experiments were run to determine 
platelet pH as a function of DMO concentration. The final experiments were 
run with DMO at  10  -3 M.  No difference was observed in equilibrium 
values from 2 to 10 min. Duplicate measurements were run for each point. 
The data were analyzed with a Visicalc program according to the equation: 
pH~ =  pKa~ +  log,o {~  (10PH~-PK--+ 1)--1} 
where [%] is concentration of DMO in platelet volume; [Td is concentra- 
tion of DMO in external volume; pKa~ is pK of DMO in the platelet cyto- 
plasm; pKa~ is pK of DMO in the external solution. 
The pKa for DMO was taken to be 6.2 for both external and internal solu- 
tions (Boron and  Roos,  1976). The  platelet count was determined in a 
hemocytometer and recorded as the mean of two readings; agreement was 
within 10%. The diluents used were either 100 mM M NaC1, 50 mM sodium 
phosphate, 5 mM KCI, 10 mM EGTA, or with NaCI replaced with 1130 mM 
PR plus 1 mM amiloride (also added to some NaC1 samples). The pHs of 
these solutions were adjusted so that a  1:1 mixture with PRP would yield 
the appropriate final pH. The pHs of the diluted PRP differed by only 0.02 
between the start and end of each experiment. 
Phosphorylation Studies 
For [32P]PO4 studies, PRP was concentrated 20-fold on a 40% BSA step 
gradient, incubated with carder-free phosphate (1 mCi/ml; New England 
Nuclear) for 1 h at 37~  then gel filtered through Sepharose 2B. The peak 
was collected, immediately added to either CL buffer or PR buffer, in- 
cubated with stirring in small plastic tubes for varying amounts of time, and 
then challenged with 10 laM ADP. The lighting was arranged so that loss 
of swirling, indicative of loss of  the discoid shape of platelets, could be eas- 
ily observed. The response of these platelets was similar to that seen when 
shape changes were measured in the spectrophotometer. For SDS gels, an 
equal volume of hot Laemmli sample buffer was added 15 s after ADP, the 
mixture boiled for 2 rain, and then frozen before analysis by gel electropho- 
resis (Laemmli,  1970). Controls were untreated platelets collected at the 
start and end of each experiment. 
Gel Analysis 
The design for urea gels was the same except that the platelets were collected 
and washed by the method of Zucker and Masiello (1983). All platelets used 
showed a marked swirling effect on rotation of the tubes. The response to 
agonists was terminated with an equal volume of ice-cold 1 M perchloric 
acid. The precipitates were kept on ice for 10 rain, collected at 12,000 g for 
2 rain, the perehloric acid carefully removed, and the pellets dissolved in 
urea sample buffer. Additional Tris was added to bring the samples to alka- 
line pH. The method was that of Daniel et al. (1981). 
Preparation of Thiophosphorylated Actomyosin 
Platelet actomyosin was prepared by the method of Adelstein and Conti 
(1975). It was thiophosphorylated with adenosine-5'-O-(3-thiotriphosphate) 
by shaking for 2 h at 30~  in the presence of 10 I.tM calmodulin, 0.1 mM 
calcium CL, and 100 p.g/ml leupeptin. In early trials myosin light chain ki- 
nase was added (generous gift of Dr. Robert S. Adelstein, National Institutes 
of Health, Bethesda, MD), but it was found that endogenous kinase was 
sufficient, and in later runs this was omitted. The actomyosin was at least 
90%  phosphorylated after the incubation and after storage in glycerol at 
-20~  for 10 d by analysis on alkaline urea gels. For unphosphorylated 
samples, incubation was in the absence of calcium, calmodulin, or kinase 
at 30~  for 2 h. 
ATPase activity was determined after reprecipitating the thiophosphory- 
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50 mM Hepes, pH 6.8. To compare the activity of the actomyosin in CL 
versus PR, the preparation was resuspended in 0.2 M KCI, 5 mM Hepes, 
0.5 mM MgCI2, 0.5 mM EGTA at pH 7.0, divided into aliquots in Eppen- 
doff tubes, and 9/10 vol of 55 mM NaCI or sodium PR in 50 mM Hepes 
and 4.8 mM MgCI2,  pH 6 or 7, was added to each sample. Then 20 I.tL 
0.1 M ATP (2 mM final) was pipetted into the cap of each tube on a rotator 
and the reaction begun by starting the rotator. The reaction was stoppedwith 
8 % final TCA and samples were placed on ice. After centrifugation, an ali- 
quot of the supernatant was taken and assayed for inorganic phosphate. The 
pellets were assayed for protein after ethanol extraction. 
Measurement of Mitochondrial Areas 
NaCI 
pH 7.02 
Mitochondrial areas were measured with a planimeter (Numonics Corp.,  NaPr 
Lansdale, PA) on micrographs of sectioned platelets in which the contours  pH 7.07 
were sharp and the double membrane and cristae clearly visible. 
Platelet Cytoskeletons 
Platelet cytoskeletons from 50 ml of blood were washed by the method of 
Zucker and Masiello (1983) but without albumin. For each point, 1.0 ml of 
washed platelet suspension was mixed with 1.0 ml of buffer containing either 
100 mM NaCI, 5 mM KCI, 50 mM sodium phosphate, 20 mM EGTA, or 
PR replacing the CL buffer.  To inhibit swelling, 0.2 mM of the amiloride 
analogue L591605 was added. Each buffer was prepared so that the 1:1 mix- 
lure gave the pH indicated. After 15 s, 10 ~tM ADP was added and incubated 
for 15 s at 37~  For realkalinization, NaOH was added to give the final pH 
values seen in Fig. 8. Piatelets were lysed with 1/5 vol of 5% Triton X-100, 
0.5  mg/ml leupeptin, and 5  mM PMSE  The final  pH of all  lysates was 
brought to 7.0. Cytoskeletons were collected on ice for 5-10 min, sedimented 
at 5,000  g  for 10 min at 4~  washed with 2.0 ml of 1:1  mixture of the 
modified Tyrode's solution, and CL at pH 7, dissolved in 0.1 ml of Laemmli 
buffer,  boiled for 2 rain, and subjected to electrophoresis on a 7.5%  SDS- 
polyacrylamide gel. 
Tryptic Peptides 
These were performed as in Naka el al. (1983).  Myosin light chain 1 was 
identified by standards and autoradiography, cut from the gel, and washed 
exhaustively in 25%  isopropanol and  10%  methanol. Slices were treated 
with 25 Izg trypsin in ammonium bicarbonate (pH 8.4) overnight at 37~ 
After repeated lyophilization to remove bicarbonate, the residue was dis- 
solved in acetic acid/formic acid/water (15:5:80)  and spotted onto a silica 
gel thin-layer plate. Electrophoresis was at 950 V for 90 min. After drying, 
chromatography was performed in a buffer of n-butyl alcohol/pyridine/ace- 
tic acid/water (32.2:25:5:20)  in an ascending direction. Autoradiography 
was performed with Kodak X-Omat R  film at  -70~ 
Sodium PR was from Sigma Chemical Co. (St. Louis, MO). The urea 
was ultrapure (Schwarz-Mann Biotech, Cleveland, OH). All other chemi- 
cals were of reagent grade. Adenosine-5"O-(3-thiotriphosphate) and cal- 
modulin  were  from  Boehringer Mannheim Biochemicals  (Indianapolis, 
IN).  [3H]H20  was from New England Nuclear, and the [14C]sucrose and 
inorganic  [32p]phosphate (carrier-free) and 2-[~C]DMO were all  purchased 
from ICN Pharmaceuticals, Inc. (Irvine, CA). 
Results 
Platelets in plasma diluted with NaCI were compared with 
identical samples diluted with the sodium salts of the weak 
acids  pyruvate,  lactate,  acetate,  or  the  nonmetabolized 
DMO. Within 30-60 s after dilution,  the shape change re- 
sponse  was  recorded  by  measuring  absorbance  in  stirred 
samples in response to 1(3 IxM ADP, a concentration of this 
agonist that gives a maximal response. At neutral pH, there 
was little difference between the different diluents. When the 
external pH was dropped below 7, the shape change response 
was almost unchanged in CL, but was markedly inhibited in 
weak acids. The weak acids caused platelet swelling, docu- 
mented  by volume measurements and  by electron  micro- 
graphs  (data not  shown).  This  swelling  was prevented by 
1 mM amiloride. 
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Figure 1. The effect of pH, on platelet shape change in PR or CL. 
Platelets in PRP were diluted  1:1 with buffer containing  100 mM 
NaC1, 50 mM sodium phosphate, 5 mM KCI, 10 mM EGTA, 1 mM 
amiloride,  or with NaC1  replaced by  sodium PR.  The pH of the 
diluent was adjusted before mixing with platelets to yield the final 
pH shown at the left of each curve.  Platelets were stirred at 37~ 
as described. The oscillatory  tracing  is  indicative of the discoid 
shape of platelets, while the increased absorbance and narrowing 
of the oscillations accompanies the change in  shape to  irregular 
spheres with filopodia. At the arrow,  10 I.tM (final) ADP is added. 
Note that there are only slight differences in the curves when plate- 
lets are diluted with sodium CL to pH 7  or 6, or when dilution is 
with sodium PR at pH 7, but that there is a  marked inhibition of 
rate of shape change if platelets are diluted into PR at a final pH of 6. 
Hemptinne et al. (1983) studied the effects of weak acids 
on the pH of muscle cytoplasm,  and reported very useful 
properties of PR. It has a relatively high pK of 4.67 and was 
found to acidify rapidly.  It was therefore chosen for system- 
atic study. Fig.  1 shows the platelet shape change response 
measured within 30 s after dilution into CL or PR at pH 7 
and 6. The shape change curve is affected very little by lower- 
ing the external pH to 6 in CL, but is strongly inhibited when 
platelets in PR are brought to pH 6  (PR6). Note that shape 
change gives  rise  to two different optical effects,  a  rise in 
mean absorbance and a diminution of the oscillations in ab- 
sorbance, which are due to stirring of the discoid platelets. 
Both are inhibited in PR6. Fig. 2 shows that the inhibited re- 
sponse  is  immediately  reversed  on alkalinization without 
further addition of agonist. These changes in optical proper- 
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Figure 2. Reversal of the effect of low pile on shape change in PRP 
diluted with NaCI or Na PR in imidazole buffer. The inhibition of 
shape change in  PR  at pH 6.02 is  immediately reversed upon 
realkalinization with small aliquots of NaOH without further addi- 
tion of agonist. Note that the extent of shape change increases as 
the pH is increased (lower curve). 
ties were correlated by phase microscopy, which  showed 
retention of discoid shape in inhibited platelets and the ap- 
pearance  of irregular  spheres  bearing  many  filopodia in 
reversed samples. 
Similar results were observed with all of the weak acids 
mentioned above. The threshold for inhibition with acetate 
at pH 6.5 was about 22 mM. Inhibition of shape change was 
observed as soon as it could be measured after dilution of 
the platelets (•15  s). 
These results suggested that we had inhibited shape change 
by decreasing phi, since weak acids of different degrees of 
hydrophobicity, including both metabolized and unmetabo- 
lized forms, gave similar results. To test this, we measured 
pH+ using the labeled DMO method (Boron and Roos, 1976; 
Gillies  and  Deamer,  1979; Deutsch  et al.,  1979). Platelet 
volumes  were  measured  in  the  same  experiments.  The 
marker for external volume in both cases was  mC-labeled 
sucrose. 
The dependence of pHi on external pH is shown in Fig. 3. 
In CL, platelets buffer pHi well over the range of 6-7 with 
a  slope of 0.33.  If only points below 6.7 are included, the 
slope of phi in chloride is 0.16. However, in PR the pHi al- 
most follows external pH; the slope is 0.81. In CL, the points 
taken with or without amiloride lie on the same line. In PR, 
only a few points were measured in the absence of  amiloride; 
these gave a  slightly higher pHi than in its presence (Fig. 
3).  To  determine  whether  our  pHi  measurements  were 
significantly affected by the volume of the mitochondria, the 
area of the cytoplasm occupied by mitochondria was esti- 
mated from electron micrographs.  Mitochondria occupied 
an area of 2.09%  (mean), with a range from 0.23 to 3.9. 
We tested whether inhibition of shape change could be due 
to swelling, by measuring platelet volumes in the presence 
and absence of amiloride in PR. Platelet volume in PRP was 
relatively constant over a 40-min period. In one experiment 
we obtained a mean volume of 8.94  +  0.25  lxm  3 over this 
period. Platelets diluted with CL swelled transiently by 5 %, 
returning to control levels by 40 min. In 43 measurements 
from nine experiments and four donors,  in which the pH 
ranged from 5.8 to 7.0, the mean volume was 7.04,  with a 
range from 5.55 to 10.20 I~m  3. In PR without amiloride, the 
volume of a platelet averaged 1.4-2.8 l.tm  3 greater than in 
CL, with greater increases at lower pUs. Amiloride at 0.5 
mM prevented an initial downward drift of absorbance in the 
shape change record and decreased the volume difference to 
0.94-1.75 ~m  3.  Amiloride at  1 mM completely eliminated 
the volume difference between platelets in CL or PR. Sam- 
ples diluted into PR6 buffer with either 0.5 or 1 mM amilo- 
ride showed the same amount of inhibition of shape change 
at low pH. 
The rate of shape change was relatively independent of  ex- 
ternal pH in CL buffer (Fig. 4, left) but highly dependent on 
pH~ (Fig. 4,  right),  with  100%  inhibition at pHi of 6,  and 
50% inhibition at pH 6.4. Similar results were obtained with 
acetate, lactate, pyruvate, and DMO at 23-65 mM. 
Since previous work had shown that shape change is cor- 
related  with  phosphorylation  of myosin  regulatory  light 
chain, it seemed most likely that decreasing pH~ would in- 
hibit this phosphorylation.  Surprisingly,  the situation was 
more complicated. We first studied phosphorylation after a 
30-s incubation in PR6 followed by an ADP stimulus stopped 
20 s later by lysis with Laemmli buffer. Table I shows  the 
results of autoradiography in the platelets labeled with 32p. 
Scans of gels across the myosin light chain, which was well 
resolved, showed an increase in endogenous myosin light 
chain  phosphorylation when  platelets  were  suspended  in 
PR6.  After the ADP stimulus,  although the increment was 
smaller,  the  final  level of phosphorylation was  about the 
same as in CL at pH 6. This conclusion was borne out by 
separating the phosphorylated myosin light chain on alkaline 
urea gels (Fig. 5). Again, there was endogenous phosphory- 
lation in PR6 (cf. lanes 3 and 2) while after ADP the level 
of phosphorylated myosin light chain was the same or slightly 
increased over that in CL (cf. lanes 5 and 4). 
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Figure 3. The pHi of platelets diluted as in Fig. 1 to different exter- 
nal pH values was estimated by the DMO method as described, al- 
lowing 10 min for equilibration. The continuous line is the line of 
no regulation. The points below pH 7.5 were estimated for sodium 
CL and gave a regression line of slope 0.31; in PR the slope was 
0.85. If only points below pH 6.7 were included, the respective 
slopes were 0.16 and 0.81. 
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Figure 4.  (Lejq) The  rate  of 
platelet shape change as a func- 
tion  of external pH was esti- 
mated from the initial,  linear 
portion of the slope under the 
conditions of Fig. 1. (x) Points 
in sodium  CL; (e) points in 
PR. (Right) The rate of plate- 
let shape change, estimated as 
at left, as a function of the pH~ 
measured  as in Fig.  3.  Note 
that while at left the CL and 
PR curves are separate,  here 
they are described by a single 
smooth curve. 
Although  myosin  was  phosphorylated  in  PR6,  the  acid 
condition  and  PR  within  the  platelet  might inhibit  act￿9 
activated ATPase, but experiments with fully phosphorylated 
actomyosin showed  that  the  ATPase  measured  under  low 
ionic strength conditions was nearly the same in PR6 as in 
CL at pH 7 or PR at pH 7. The rates ranged from 83 to 125 % 
of the CL rates at pH 7. 
On the other hand, incubation in PR6 had a striking effect 
on the composition of the platelet cytoskeleton, as shown in 
Fig. 6.  Cytoskeletons made from control platelets in CL or 
PR6 (lane 1) contained only traces of myosin heavy chain 
and small amounts of actin. Cytoskeletons prepared 15 s af- 
ter ADP stimulation in CL at pH 6 or 7  or in PR at pH 7 
contained larger amounts of both myosin and actin (lanes 4, 
7, and 5). This increase in myosin and actin was almost com- 
pletely inhibited when platelets were stimulated with ADP 
in PR6 0aries 2 and 6) and the resulting cytoskeletons resem- 
bled the unstimulated controls. These results were not due 
to a difference in the buffer composition or pH at the time 
of lysis, since control experiments in which both pH and salt 
were varied showed that these did not alter the myosin con- 
tent of the cytoskeleton. To see whether an increase in myo- 
sin and actin would correlate with rapid shape change after 
realkalinization,  we  studied  the  cytoskeletons  of controls 
with those of PR6 platelets that were first treated with ADP 
and then brought to final pHs of 7 and above.  Under these 
conditions the shape change response recovers, as shown in 
Fig. 2. Cytoskeletons from these reversed platelets now con- 
mined some myosin heavy chain and increased actin (Fig. 7). 
Although shape change occurred rapidly after realkaliniza- 
tion, the amount of myosin heavy chain in the cytoskeletons 
was less than that in samples that had never been exposed to 
PR6;  cf lanes  7-9 in Fig.  7  with lanes 3-5. 
The  discrepancy  between  myosin  phosphorylation  and 
myosin association with the cytoskeleton was analyzed fur- 
ther by examining very early time points at pHs from 6  to 
7.  We found that if washed platelets were stimulated with 
ADP very rapidly after dilution  into PR (10-20 s) myosin 
Table L  Phosphorylation of Myosin Light Chain 
in lntact Platelets  Suspended in Buffer with 50 mM CL 
or 50 mM PR 
Experiment  CL  PR  PR/CL 
pH 6.1 
Control  1.6  2.1  1.3 
ADP  2.5  2.5  1.0 
pH 6.0 
Control  0.84  1.14  1.36 
ADP  1.12  1.30  1.16 
Platelets were concentrated,  incubated with [32P]phosphate as described,  gel 
filtered, and diluted 1:1 with CL or PR buffer to the final pH shown. 20 s after 
the addition  of ADP(50  ltM  in experiment  1 and 25  ~tM  in experiment  2), 
platelets were lysed with an equal volume of 2% Laenmali sample buffer. Sam- 
pies were subjected to electrophoresis and autoradiographs were prepared. The 
results shown are the ratio of the density at the position of the light chain on 
autoradiographs  to loading as determined on the Coomassie Blue-stained  gel. 
Figure 5. An alkaline urea gel of the perchloric acid precipitate of 
whole platelets. The washed platelets were diluted  1:1 with CL at 
pH 6 (lanes 2 and 4) or PR6 (lanes 3 and 5). Controls were precipi- 
tated with perchloric acid after 15 s. 20 s later, ADP at 20 ~tM was 
added to the platelets used for lanes 4 and 5. Note that lanes 4 and 
5 show an increased amount of phosphorylated myosin light chain 
marked by the position of the arrow (PLCO. Note that there is also 
an increase in endogenous phosphorylation  in lane 3 as compared 
with lane 2. Lane I is an actomyosin standard in which the myosin 
light chain was dephosphorylated (ULC~  and LC2 are the positions 
of the unphosphorylated  regulatory  light chain  and myosin light 
chain 2, respectively). 
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cytoskeleton  from platelets  washed  by the method of Dr.  M.  B. 
Zucker (see Materials  and Methods).  The platelets  as prepared are 
discoid and show a good shape change response with ADP. Platelets 
are mixed at room temperature  1:1 with either CL buffer containing 
100 mM sodium chloride, 5 mM KC1, 50 mM sodium phosphate, 
10 mM EGTA, or with PR buffer in which the CL is replaced with 
PR.  PR buffer also contained 0.2 mM of the amiloride analogue 
L591605 to inhibit swelling. Each buffer is prepared so that the hl 
mixture is pH 6.0 or 7.0, as required.  At exactly  15 s after mixing, 
ADP is added and 15 s later the platelets  are lysed by the addition 
of 1/5 vol of 5 % Triton-X  100, 0.5  mg/ml leupeptin,  and 5  mM 
PMSE  The cytoskeletons  are collected on ice for 10 min.  They 
are  sedimented,  washed  once with 2.0 ml of 1:1  mixture of the 
wash solution and CL buffer at pH 6.0, and then dissolved in 0.1 ml 
of Laemmli buffer  for electrophoresis.  Control experiments  also 
showed that the composition of  the cytoskeletons did not depend on 
the pH at the time of lysis. Lane I, PR control, pH 6.0; lane 2, PR 
ADP, pH 6.0; lane  3, whole platelet  lysate;  lane 4, CL ADP, pH 
6.0; lane 5, PR ADP, pH 7.0; lane 6, PR ADP, pH 6.0; lane 7, CL 
ADP,  pH 7.0. 
phosphorylation was inhibited in parallel with shape change 
and myosin association with the cytoskeleton (Fig. 8). As the 
time interval after dilution into PR at low pH was increased, 
the extent of myosin light chain phosphorylation increased, 
so that by 30 s it was already nearly constant over the range 
pH 6-7 (Fig.  8, uppermost curve).  When we examined en- 
dogenous myosin light chain phosphorylation as a function 
of time in PR6 buffer, we observed a slow increase up to 10 
min from a just discernable  effect at  15-20 s. 
We performed tryptic peptide analysis on the myosin light 
chain labeled with [32P]phosphate after 5 min incubation in 
PR6 and compared it with the results of 0.1  U/ml thrombin 
for 30 s. We detected two major radioactive spots after treat- 
ment with PR with mobilities similar to those reported after 
stimulation of platelets for 5 rain with phorbol esters (Naka 
et al.,  1983). The two-dimensional autoradiograph is shown 
in Fig.  9. 
Discussion 
Our  measurements  show  that  the  rate  of  platelet  shape 
change is sensitive to pHi over the range of 7-6, with 50% 
inhibition  at  pH  6.4.  Platelets  also  respond  to  an  acid- 
induced drop in pH by swelling. First, then, how accurate are 
the pH measurements, and second, is the inhibition of shape 
Figure  7. Reversal effect. The cytoskeletons  were prepared as de- 
scribed in Fig.  7. In this case,  after ADP addition,  platelets  were 
treated  with an appropriate amount (predetermined)  of NaOH for 
15 s before lysis. Platelets were diluted  1:1 with PR buffer. Lane 1, 
PR control, pH 7.0; lane 2, PR control, pH 6.0; lane 3, PR 7.8 ADP; 
lane 4, PR 7.4 ADP; lane 5, PR 7.0 ADP; lane 6, PR 6 ADP; lanes 
7, 8, and 9, PR 6 ADP with pHs reversed to 7.0, 7.4, and 7.8, respec- 
tively. To the samples in PR6 buffer we further added NaOH so that 
the final pH gave the values indicated (lanes  7, & and 9). ADP was 
omitted for controls. After lysis, sufficient NaOH or HCI was added 
so that the pH of all lysates was 7.0. 
change really due to lowered pH,  or could it be caused by 
swelling? 
There is only a small effect of DMO concentration on the 
pH measured.  At 50 IxM (used here), the pH was only 0.06 
pH units less than with 1 mM DMO. If the more alkaline pH 
is due to DMO binding at 1 mM, there can be very little re- 
sidual  binding  at  50  I.tM.  DMO equilibrates  rapidly,  cer- 
tainly within 2 min, and most probably across internal mem- 
branes.  Of these the only ones likely to take up DMO are 
those of mitochondria, which have mildly alkaline compart- 
ments  (Deutsch  et  al.,  1981),  but mitochondria occupy at 
most only 2 % of the platelet volume.  DMO is a  weak acid 
and so should be excluded from acid compartments such as 
lysosomes and  dense  granules,  making  it a  better  marker 
than weak bases for a cell such as the platelet which has more 
I00- 
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Figure  8.  Correlation of myosin 
light chain phosphorylation with 
shape change and myosin and ac- 
tin association  with the cytoskele- 
ton as a function of pH after 20 or 
30 s incubation in PR6. The plate- 
lets were prepared as in Fig. 7 but 
the  time  interval  after  dilution 
into buffer was strictly monitored 
before  the addition  of ADP.  Re- 
sults are expressed as a percent of 
the maximum, which was pH 7, 
except for the longer incubation in PR, which gave maximum phos- 
phorylation after ADP at pH 6.25. (e) Shape change at 20 or 30 s; 
(o)  myosin  association  with the cytoskeleton  at 20 or 30 s;  (zx) 
myosin light chain phosphorylation at 20 s; (v) myosin light chain 
phosphorylation at 30 s. Note that there is a good correlation of all 
three parameters  at 20 s but that by 30 s myosin light chain phos- 
phorylation increases  without a change in the inhibition  of shape 
change or myosin association  with the cytoskeleton. 
The Journal of Cell Biology, Volume  105, 1987  1766 Figure  9.  Two-dimensional tryptic  peptide  map  of the  myosin 
regulatory light chain from platelets that had been preincubated 
with  [32P]phosphate as  described,  washed, and  then  incubated 
with PR buffer at pH 6.0 for 5 min.  Two major spots are seen, 
marked a and b. These are similar in position to the sites phos- 
phorylated by protein kinase C (a) and myosin light chain kinase 
(b) as shown by Naka et al. (1983). 
granules than mitochondria.  Hence we conclude that our 
measurements of pHi are good to one-tenth of a pH unit and 
probably better. 
Our results provide a good value for platelet volume. Plate- 
lets contain an elaborate system of long indentations of the 
plasma membrane,  the so-called open canalicular system. 
Previous studies that used iodinated albumin as an external 
marker (Giles,  1981; Feinberg et al.,  1974) found volumes 
1-2 Ixm  3 larger than in our study. Sucrose can penetrate the 
open canalicular system more completely to yield more ac- 
curate values. Interestingly, the mean volume found by Bull 
and Zucker (1965) using a  Coulter counter for platelets at 
room temperature with citrate as an anticoagulant was 7.1 
lxm  3, agreeing well with our mean value of 7.04  IJ.m  3. 
The swelling response is most likely due to a sodium-pro- 
ton exchange activated by the decreased pHi, since it is in- 
hibited by amiloride. The existence of such antiporters has 
been shown in a number of cell types (Grinstein et al., 1984; 
Moolenaar et al., 1984; Pouyssegur et al., 1984). The inhibi- 
tion of shape change in PR6 was as strong in 1 mM amilo- 
ride, which prevented swelling completely at pH 6.11, as in 
0.5 mM amiloride. We conclude that the inhibition of  platelet 
shape change at low pHi cannot be due to platelet swelling. 
Anderson and Foulks (1978) reported that the small organic 
anions formate, acetate, butyrate, hexanoate, and octanoate 
did not alter the pH dependence of the rate of shape change 
under alkaline conditions, as compared with sodium CL, but 
produced strong inhibition at pHs below 7.  Although they 
ascribed these results to a surface effect, their data, coupled 
with the observation that sulfonates (probably less perme- 
able) were much less effective, fit our interpretation that the 
fundamental variable is pHi. Independent confirmation of a 
change in pH comes from a  report of Zieve and Solomon 
(1966)  who found that platelets buffered their pHi poorly 
when the pCO2 was increased. 
In  summary,  lowering pHi inhibits  shape change,  but a 
decrease to •6.4  is necessary for a 50% inhibition. We con- 
clude that a small change in the pH range of 6.8-7.3  would 
only affect the rate of shape change by ,,o10%. Our results 
do not fit well with a recent report from Siffert and Akker- 
man (1987). They found that lowering sodium to 40 mM and 
adding  ethylisopropyl-amiloride completely inhibited  the 
calcium signal from 0.1 U/ml thrombin and inhibited activa- 
tion.  These  treatments  should  lower  pHi  by  0.1-0.2  pH 
units. They concluded that the sodium-proton antiporter was 
necessary for activation. Our results suggest that alkalinlza- 
tion is more likely to be an effect of platelet activation than 
a requirement for the earliest response, i.e., calcium mobili- 
zation and shape change. To explain the discrepancy, it would 
be necessary to measure the calcium signal at the same time 
as intracellular pH and shape change. We were not able to 
measure the calcium transient with fura-2 in PR6 due to 
quenching of the fluorescence. 
Myosin phosphorylation is closely correlated with shape 
change induced by thrombin, ADP, or cold (Daniel et al., 
1981, 1984;  Nachmias et al.,  1985).  In the present experi- 
ments this correlation was only sustained if  the platelets were 
stimulated within 20 s after being exposed to PR6. The phos- 
phorylation in PR6 appeared to be largely endogenous (Table 
I) and it increased with time (data not shown). It is known 
that phosphorylating the myosin regulatory light chains in 
platelets increases interaction of myosin with actin (Axiel- 
stein and Conti, 1975). Therefore, inhibition of shape change 
might  be ascribed  to  inhibition of actin-activated myosin 
ATPase either by the lower pH, or by the presence of PR. 
However, our results indicated only a very weak (maximum 
17%) effect of lowered pH and PR on actomyosin ATPase ac- 
tivity. At later time points PR even activated the actomyosin 
ATPase. 
In contrast to these negative effects, the inhibition of shape 
change correlated well with inhibition of myosin and actin 
association with the cytoskeleton, even when cytoskeletons 
were formed at the same final pH. Furthermore, when plate- 
lets  were  treated  with  ADP  in  PR6  buffer  and  then 
realkalinized,  myosin  and  actin  again  became  associated 
with the cytoskeleton in parallel with the return of shape 
change (Fig. 7). This association of actin and myosin with 
the cytoskeleton would appear to reflect active myosin-actin 
interaction. An independent inhibition of actin association 
could be ruled out. If we added excess filamentous actin to 
cytoskeletons in PR6, we did not cause increased myosin as- 
sociation (data not shown). A similar effect was seen during 
studies  of cold-induced  shape  change  (Nachmias  et  al., 
1985).  Thus, a change in actin cannot explain the results. 
Our results can be interpreted by assuming that there are 
two  effects of lowering  pHi:  a  rapid  one,  which  inhibits 
some aspect of transduction, and a slower one, which leads 
to phosphorylation of myosin regulatory light chain. Over a 
much longer time scale (minutes) this leads to shape change. 
It is  known that platelet myosin light chain can be phos- 
phorylated on two sites in vitro, one due to the light chain 
kinase and one due to protein kinase C (Naka et al.,  1983). 
When the C kinase site is phosphorylated in smooth muscle, 
it does not stimulate the actin-activated MgATPase and even 
decreases it over controls when the myosin light chain kinase 
site is subsequently phosphorylated (Nishikawa et al., 1983; 
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platelets are stimulated  with phorbol esters.  These inhibit 
shape change due to agonists (Yoshida et al., 1986) but cause 
slow shape change with little association of myosin with the 
cytoskeleton  (Carroll  et  al.,  1982).  Phorbol  esters  cause 
phosphorylation of both the myosin light chain kinase site 
and the C kinase site on myosin regulatory light chain (Naka 
et al.,  1983).  We found two radioactive spots after tryptic 
peptide digests of myosin light chain after PR6 incubation 
(Fig.  9).  By relative mobility and comparison  with  spots 
found after thrombin, these appear to be similar to the myo- 
sin light chain kinase site and the protein kinase C site. They 
were phosphorylated to an approximately equal extent.  In 
addition, we found strong phosphorylation of the 47-kD band 
in whole platelets in PR6. This is known to be a good sub- 
strate for the C kinase. Our results suggest that PR6 can, like 
phorbol esters, activate protein kinase C. 
A second possibility is that the signaling process is intact, 
and myosin becomes sufficiently phosphorylated (in part en- 
dogenously and in part by the ADP signal) at the myosin light 
chain kinase site to be activated, but some other step inhibits 
shape change until the pH is increased. For example, perhaps 
myosin cannot change conformation from the folded to the 
unfolded  form  (Scholey et al.,  1980;  Trybus and  Lowey, 
1982)  until  the pH is reversed.  This would imply that al- 
though phosphorylated myosin is activated it can only exert 
active tension in the filamentous form. 
In summary, part of the mechanism required for platelet 
shape change  is reversibly inhibited by lowering the pHi. 
This mechanism is not the overall level of myosin phosphory- 
lation,  nor can it be accounted for by an inhibition  in ac- 
tomyosin ATPase. Thus, myosin phosphorylation can be dis- 
sociated from shape change. In some respects, the response 
of platelets to lowered pH is similar to the response to phor- 
bol esters, which also rapidly inhibit shape change but cause 
phosphorylation of the regulatory myosin light chain on two 
sites. On the other hand, our results show that the association 
of myosin and actin with the cytoskeleton correlates closely 
with the ability of platelets to change shape. This strengthens 
the conclusion that active interaction of myosin and actin is 
necessary for platelet shape change (Daniel et al.,  1984). 
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